Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer-Reference-Cited by-同舟云学术

Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer

Published:2008-02-08 Issue:6 Volume:62 Page:1009-1014
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Park Se Hoon,Cho Eun Kyung,Kim Yujin,Kyung Sun Young,An Chang Hyeok,Lee Sang Pyo,Park Jeong Woong,Jeong Sung Hwan,Lee Jae-Ik,Choi Soo Jin,Park Jinny,Shin Dong Bok,Lee Jae Hoon

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-008-0690-1.pdf

Reference21 articles.

1. Hansen HH (1992) Management of small-cell cancer of the lung. Lancet 339:846–849

2. Sundstrom S, Bremnes RM, Kaasa S, Aasebo U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S (2002) Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol 20:4665–4672

3. Popat S, O’Brien M (2005) Chemotherapy strategies in the treatment of small cell lung cancer. Anticancer Drugs 16:361–372

4. Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85–91

5. Eckardt J, Depierre A, Ardizzoni A, Von Pawel J, Fields S (1997) Pooled analysis of topotecan (T) in the second-line treatment of patients (pts) with sensitive small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 16: abstr 1624

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of nab-paclitaxel plus PD-1/PD-L1 inhibitor on chemorefractory relapsed small-cell lung cancer;Future Oncology;2023-04-28

2. Evaluation of topotecan monotherapy for relapsed small-cell lung cancer after amrubicin monotherapy failure;Journal of Rural Medicine;2021

3. Mechanism of a Novel Camptothecin-Deoxycholic Acid Derivate Induced Apoptosis against Human Liver Cancer HepG2 Cells and Human Colon Cancer HCT116 Cells;Recent Patents on Anti-Cancer Drug Discovery;2020-01-03

4. Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cells;Cancer Cell International;2017-03-07

5. Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer;Clinical Lung Cancer;2017-03